IGM Financial Inc. (TSE:IGM – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the six research ...

We could all use some extra cash on hand, and this dividend stock could create loads of it. The post Invest $15,000, Create ...

IGM Financial Inc. (OTCMKTS:IGIFF – Get Free Report) saw a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 691,700 shares, an ...

Analyst Tom Mackinnon of BMO Capital maintained a Hold rating on IGM Financial (IGIFF – Research Report), retaining the price target of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Assets Under Management and Advisement (AUM&A) represents the consolidated AUM and AUA of IGM Financial's core businesses IG Wealth Management and Mackenzie Investments. In the Wealth Management ...

Fintel reports that on January 10, 2025, Stifel downgraded their outlook for IGM Biosciences (NasdaqGS:IGMS) from Buy to Hold. Analyst Price Forecast Suggests 858.18% Upside As of December 23, 2024, ...

Stifel downgraded IGM Biosciences (IGMS) to Hold from Buy with a price target of $2.50, down from $27. Th firm cites the company’s “surprising ...

IGM Biosciences has decided to halt development of imvotamab and IGM-2644, two IgM-based bispecific antibody T cell engagers for autoimmune diseases, and cut its staff by 73%. The biotechnology ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Upgrade to begin using 40 years of financial statements and get so much more. Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.